Padikara Kutty Satheeshkumar

Padikara Kutty Satheeshkumar

Auto-generated profile, based on publicly available information

Padikara Kutty Satheeshkumar

Department of Botany, Institute of Science, Banaras Hindu University, Varanasi, India

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2012 in Chemico-Biological Interactions
Verified
Journal Article
Closed access
DMDeepa Mundekkad
Deepa Mundekkad
TSThavamani Sureshkumar
Thavamani Sureshkumar
PSPadikara Kutty Satheeshkumar
Padikara Kutty Satheeshkumar
SPSulochana Priya
Sulochana Priya

26 February 2013 in Nutrition and Cancer
Verified
Journal Article
Closed access
DMDeepa Mundekkad
Deepa Mundekkad
TSThavamani Sureshkumar
Thavamani Sureshkumar
PSPadikara Kutty Satheeshkumar
Padikara Kutty Satheeshkumar
SPSulochana Priya
Sulochana Priya
Morus species had been used widely in the traditional medicines for various diseases. In this study we report the in vitro antiproliferative activity of the methanol extract of Morus alba. The extract is capable of inducing cytotoxicity in human colon cancer (HCT-15) cells (IC50 = 13.8 μg/ml) and breast cancer (MCF-7) cells (IC50 = 9.2 μg/ml), resulted in significant morphological changes of the cells, fragmentation of DNA, and caspase-3 activation- characteristics of apoptosis. It downregulated the amount of nitric oxide (NO) produced as a result of inducible nitric oxide (iNOS) activation. The HPLC analysis of the extract showed epicatechin (20%), myricetin (10%), quercetin hydrate (12%), luteolin (12%), and kaempferol (6%) as the major active components and ascorbic acid, gallic acid, pelargonidine, and p-coumaric acid as the minor components. To the best of our knowledge, this is the first report showing the downregulation of iNOS and induction of apoptosis by M. alba extract.

8 February 2020 in Molecular Biotechnology
Verified
Journal Article
Open access
PDF file
PSPadikara Kutty Satheeshkumar
Padikara Kutty Satheeshkumar
Single chain variable fragments (scFvs) are generated by joining together the variable heavy and light chain of a monoclonal antibody (mAb) via a peptide linker. They offer some advantages over the parental mAb such as low molecular weight, heterologous production, multimeric form, and multivalency. The scFvs were produced against more than 50 antigens till date using 10 different plant species as the expression system. There were considerable improvements in the expression and purification strategies of scFv in the last 24 years. With the growing demand of scFv in therapeutic and diagnostic fields, its biosynthesis needs to be increased. The easiness in development, maintenance, and multiplication of transgenic plants make them an attractive expression platform for scFv production. The review intends to provide comprehensive information about the use of plant expression system to produce scFv. The developments, advantages, pitfalls, and possible prospects of improvement for the exploitation of plants in the industrial level are discussed.

2 June 2024
Verified
Book Chapter
Closed access
PDF file
ASAakanksha Singh
Aakanksha Singh
PSP. K. Satheeshkumar
P. K. Satheeshkumar

1 December 2011 in Journal of Biotechnology
Verified
Journal Article
Closed access
KSKrishnan Sushma
Krishnan Sushma
MVMookambeswaran A. Vijayalakshmi
Mookambeswaran A. Vijayalakshmi
VKVenkataraman Krishnan
Venkataraman Krishnan
PSPadikara Kutty Satheeshkumar
Padikara Kutty Satheeshkumar

26 August 2020 in Proteomics
Verified
Journal Article
Closed access
PDF file
STSikha Thoduvayil
Sikha Thoduvayil
GDGunasekaran Dhandapani
Gunasekaran Dhandapani
RBRahul Brahma
Rahul Brahma
Rex Devasahayam Arokia BalayaRex Devasahayam Arokia Balaya
Rex Devasahayam Arokia Balaya
KMKiran K. Mangalaparthi
Kiran K. Mangalaparthi
MMM. G. Madanan
M. G. Madanan